AGP Executive Report
Last update: 17 minutes agoDiabetes Treatment: Aspen has approval to sell generic injectable semaglutide in South Africa, with launches expected in the coming months. More than four million South African adults live with diabetes, though the approval alone does not confirm what the medicine will cost. Health System: Government is pursuing partnerships to strengthen vaccine manufacturing, while national health insurance remains in planning. Cancer Care: A Gqeberha patient has turned to crowdfunding after hospital scanners failed, highlighting gaps in access to diagnosis. Workplace Health: Employment and Labour’s November 12–13 symposium will bring health and safety specialists together to improve workplace protection. Climate & Clinics: Questions over KZN clinics’ readiness for El Niño underline the need to prepare health services for changing conditions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.